CytoMed Therapeutics
GDTC
$2.10
Share price
-2.33%
Change (1 day)
-37.31%
Change (1 year)
Categories
CytoMed Therapeutics (GDTC) - P/B ratio
P/B ratio as of April 2024 : 2.50
According to CytoMed Therapeutics's latest financial reports the company has a price-to-book ratio of 2.50.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
CytoMed Therapeutics - P/B ratio (from 2023 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 6.63 | |
| 2022-12-31 | N/A | |
| 2021-12-31 | N/A |